Abstract:Thoracic endovascular aortic repair (TEVAR) has become the preferred treatment for Stanford type B aortic dissection (TBAD). However, distal stent graft-induced new entry (dSINE) remains a significant long-term complication, which may result in persistent false lumen perfusion, progressive aneurysmal degeneration, and even aortic rupture, thereby adversely affecting long-term outcomes. With the expanding application of TEVAR, increasing attention has been paid to the mechanisms, risk factors, and management strategies of dSINE. This review systematically summarizes the epidemiology, histopathological and biomechanical mechanisms, as well as patient- and device-related risk factors for dSINE following TEVAR in TBAD. Current preventive and therapeutic strategies, including stent sizing optimization, secondary TEVAR, and emerging endovascular techniques, are also discussed, aiming to provide insights for reducing dSINE incidence and improving long-term prognosis.